Rankings
▼
Calendar
ALKS Q4 2016 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$214M
Gross Profit
$179M
83.6% margin
Operating Income
-$24M
-11.0% margin
Net Income
-$21M
-9.9% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+18.5%
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
-$2M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$517M
Stockholders' Equity
$1.2B
Cash & Equivalents
$186M
← FY 2016
All Quarters
Q1 2017 →